retatrutide clinical trial results weight loss retatrutide Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Nearly 30% average weight loss
Pay in 4 interest-free payments of $5.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12

























